Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025 /PRNewswire/ -- Alamar Biosciences ...

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce ...

Precision BioSciences (NASDAQ:DTIL – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect Precision BioSciences to ...

Precision Medicine serves as a critical bridge connecting fundamental research with clinical applications, focusing on the rapid translation of laboratory ...

When tradition meets modernity, the results can be spectacular. Enter the Nissan Z NISMO Precision Sushi Knife – a culinary ...

These qualities define both the Nissan Z and the centuries-old tradition of Japanese knifemaking. To honor that shared DNA, ...

While not a katana, like the shape the roofline is modeled after on the Nissan Z, the limited-edition Z NISMO Precision Sushi ...

DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...

Analysts have set 12-month price targets for Precision BioSciences, revealing an average target of $53.5, a high estimate of $60.00, and a low estimate of $34.00. Staying constant with the previous ...

Alamar's technology empowers scientists to achieve groundbreaking insights in biomarker discovery, drug development, and disease research. Through these new partnerships, researchers in Asia-Pacific ...

Precision BioSciences (DTIL) announced the presentation of preclinical data for its PBGENE-DMD development program for the treatment of ...